FDA Approved: ZORTRESS — Supplemental Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

FDA approves a supplemental application for ZORTRESS (everolimus) from Novartis Pharmaceuticals Corporation, expanding its approved indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Zortress (everolimus)

Snippet

SUPPL AP for ZORTRESS (EVEROLIMUS)